Breadcrumb
- News and Events
- News
- Content
RI-MUHC researcher invited to provide expert testimony to the House of Commons regarding her project, the Montreal Antenatal Well-Being Study...
MUHC patients are the first enrolled in a new global Phase 1 clinical trial testing Actinium-225, a therapeutic agent used in nuclear precision medicine
Scientist, RI-MUHC, 5252 de Maisonneuve site
...
Tuesdays, 4 p.m. to 5 p.m.